RRC ID 27891
著者 Sishi BJ, Loos B, van Rooyen J, Engelbrecht AM.
タイトル Doxorubicin induces protein ubiquitination and inhibits proteasome activity during cardiotoxicity.
ジャーナル Toxicology
Abstract Anthracycline-induced cardiotoxicity is a clinically complex syndrome that leads to substantial morbidity and mortality for cancer survivors. Despite several years of research, the underlying molecular mechanisms remain largely undefined and thus effective therapies to manage this condition are currently non-existent. This study therefore aimed to determine the contribution of the ubiquitin-proteasome pathway (UPP) and endoplasmic reticulum (ER)-stress within this context. Cardiotoxicity was induced with the use of doxorubicin (DXR) in H9C2 rat cardiomyoblasts (3 μM) for 24 h, whereas the tumour-bearing GFP-LC3 mouse model was treated with a cumulative dose of 20 mg/kg. Markers for proteasome-specific protein degradation were significantly upregulated in both models following DXR treatment, however proteasome activity was lost. Moreover, ER-stress as assessed by increased ER load was considerably augmented (in vitro) with modest binding of DXR with ER. These results suggest that DXR induces intrinsic activation of the UPP and ER stress which ultimately contributes to dysfunction of the myocardium during this phenomenon.
巻・号 309
ページ 23-9
公開日 2013-7-5
DOI 10.1016/j.tox.2013.04.016
PII S0300-483X(13)00120-0
PMID 23639627
MeSH Animals Cardiotoxins / pharmacology* Doxorubicin / pharmacology* Enzyme Activation / drug effects* Enzyme Activation / physiology Female Mice Mice, Transgenic Myocytes, Cardiac / drug effects Myocytes, Cardiac / enzymology Proteasome Endopeptidase Complex / metabolism* Proteasome Inhibitors / pharmacology* Random Allocation Rats Ubiquitination / drug effects* Ubiquitination / physiology
IF 4.099
引用数 26
WOS 分野 PHARMACOLOGY & PHARMACY TOXICOLOGY
リソース情報
実験動物マウス RBRC00806